FDA approves combo drug to treat endometrial carcinoma

Drug Discovery |  News | 0 Comment | 19 Sep, 2019

Eisai and Merck have announced that the U.S. Food and Drug Administration (FDA) approved the combination of LENVIMA, the orally available kinase inhibitor discovered by Eisai, plus KEYTRUDA...Read more

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab)

Drug Discovery |  News | 0 Comment | 18 Sep, 2019

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva® (obinutuzumab) f...Read more

FDA grants priority review for Merck’s Ebola Vaccine

Drug Discovery |  Influencers | 0 Comment | 17 Sep, 2019

Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted pri...Read more

Certara launches V8.2 of Phoenix PK/PD modeling & simulation software for drugs

Drug Discovery |  News | 0 Comment | 15 Sep, 2019

Certara®, the global model-informed drug development and decision support leader, on 12 Sep 2019, announced the launch of Phoenix® 8.2, the industry gold standard in pharmacoki...Read more

Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the Congress of European Committee for Treatment and Research in Multipl...Read more

Hansoh Pharma, Atomwise partner for AI Drug Discovery

Drug Discovery |  News | 0 Comment | 12 Sep, 2019

Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificia...Read more

Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

Drug Discovery |  News | 0 Comment | 10 Sep, 2019

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW)...Read more

Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan

Drug Discovery |  News | 0 Comment | 30 Aug, 2019

Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and software for research and development of drugs, announced today the ap...Read more

THC Global Groups' Australalia's Facility Opened by Federal Minister for Health

Drug Discovery |  News | 0 Comment | 22 Aug, 2019

THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal Minister for Health, The Honourable Greg Hunt MP. The Southport Fac...Read more

FDA fast tracks AstraZeneca's FARXIGA

Drug Discovery |  News | 0 Comment | 28 Aug, 2019

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to delay the progression of renal ...Read more

Japan's BioWa extends partnership with Cantargia

Drug Discovery |  News | 0 Comment | 27 Aug, 2019

Cantargia AB and BioWa Inc. have signed an extension of the license agreement around the BioWa proprietary POTELLIGENTTechnology for production of Cantargia’s antibody drug candidate ...Read more

Voronoi selects CDD Vault platform to manage Drug Discovery Data

Drug Discovery |  News | 0 Comment | 23 Aug, 2019

Voronoi, drug discovery and development biotech company in Korea has announced that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its...Read more

Innovent to develop & commercialize a novel diabetes medicine in China

Drug Discovery |  News | 0 Comment | 22 Aug, 2019

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high-quality medicines, has announced that it has entered into a licensing agreement with ...Read more

FDA approves new antibiotic to treat community-acquired bacterial pneumonia

Drug Discovery |  News | 0 Comment | 20 Aug, 2019

The U.S. Food and Drug Administration, on 19 August 2019, approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another op...Read more

FDA approves novel treatment for highly drug-resistant forms of TB

Drug Discovery |  News | 0 Comment | 19 Aug, 2019

Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA), on 14 August 2019, for treating some of the...Read more

Roche gets approval for oncology drug, Rozlytrek

Drug Discovery |  News | 0 Comment | 16 Aug, 2019

Genentech, a Roche’s subsidiary announced that the US Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, me...Read more

Certara Introduces Version 19.6 of its D360 Scientific Informatics Platform

Drug Discovery |  News | 0 Comment | 15 Aug, 2019

Certara®, the global model-informed drug development and decision support leader, on 30 July 2019, announced the launch of version 19.6 of D360, its scientific informatics platform for ...Read more

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Drug Discovery |  News | 0 Comment | 14 Aug, 2019

Bayer AG and BlueRock Therapeutics hasannounced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on d...Read more